Last updated on 10-8-2022 by Pierre Daubresse
Peer reviewed scientific article
Anglais
Auteurs
Adriana Romaní Vidal; Vaughan, Aisling; Francesco Innocenti; Soledad Colombe; Lina Nerlander; Natalia Rachwal; Bruno Christian Ciancio; Mougkou, Aikaterini; Carlos Carvalho; Enrique Delgado; Piers Mook; Géraldine de Muylder; Michael Peeters; Tencho Tenev; Elitsa Golkocheva-Markova; Veronika Vorobieva Solholm Jensen; Anders Koch; Julie Figoni; Cécile Brouard; Georgia Nikolopoulou; Anastasia Zisouli; Niamh Murphy; Annemarie Broderick; Lital Goldberg; Rivka Rich; Hecht Sagie, Lior; Maria Elena Tosti; Suligoi, Barbara; Rosa Joosten; Roan Pijnacker; Ingvild Fjeldheim; Eli Heen; Małgorzata Stępień; Piotr Polański; Rui Tato Marinho; João Vieira Martins; Carmen Varela; Ana Avellón; Emmi Andersson; Marie Jansson Mörk; Sema Mandal; Watson, Conall; Laura Coughlan; Meera Chand; Claire Neill; Declan T Bradley; Kathy Li; Maureen O'Leary; Neil McInnes; Christopher J Williams; Moore, Catherine; Ardiana Gjini; Erika Duffell; Richard PebodyMots-clés
Résumé:
Following the report of an excess in paediatric cases of severe acute hepatitis of unknown aetiology by the United Kingdom (UK) on 5 April 2022, 427 cases were reported from 20 countries in the World Health Organization European Region to the European Surveillance System TESSy from 1 January 2022 to 16 June 2022. Here, we analysed demographic, epidemiological, clinical and microbiological data available in TESSy. Of the reported cases, 77.3% were 5 years or younger and 53.5% had a positive test for adenovirus, 10.4% had a positive RT-PCR for SARS-CoV-2 and 10.3% were coinfected with both pa…